Hereditary angioedema: First report of the Brazilian registry and challenges

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages

  Grumach, A S ^a   Valle, S O R ^b   Toledo, E ^c   De Moraes Vasconcelos, D ^a   Villela, M M S ^d   Mansour, E ^d   Pinto, J A ^e   Campos, R A ^f   Franca A T ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c School of Sao Jose Do Rio Preto   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; DANAZOL;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRAZIL; CHILD; CLINICAL FEATURE; DISEASE REGISTRY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SKIN EDEMA;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; BRAZIL; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84874115343     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04670.x     Document Type: Article

References (28)

1. Davis AE 3rd,. New treatments addressing the pathophysiology of hereditary angioedema. Clin Mol Allergy 2008; 6: 2-7.
2. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139: 379-394.
3. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López- Trascasa M,. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 2005; 94: 498-503.
4. Nzeako UC, Frigas E, Tremaine WJ,. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001; 161: 2417-2429.
5. Nzeako UC,. Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective. World J Gastroenterol 2010; 16: 4913-4921.
6. Reshef A, Leibovich I, Goren A,. Hereditary angioedema: new hopes for an orphan disease. Isr Med Assoc J 2008; 10: 850-855.
7. Clinical Protocol and Therapeutic Guidelines [Protocolo Clínico e Diretrizes Terapêuticas]-Ordinance Brazilian Health Ministry number 109, of April 23rd, 2010. Brazil
8. Huang YT, Lin YZ, Wu HL, Chiu TF, Lee KM, Tsai HY, et al. Hereditary Angioedema: A Family Study. Asian Pac J Allergy Immunol 2005; 23: 227-233.
9. Fabiani JE, Avigliano A, Dupont JC,. Hereditary angioedema. Long-term follow-up of 88 patients. Experience of the Argentine Allergy and Immunology Institute. Allergol Immunopathol (Madr) 2000; 28: 267-271.
10. Eidelman FJ,. Hereditary angioedema: new therapeutic options for a potentially deadly disorder. BMC Blood Disord 2010; 10: 3-9.
11. Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363: 532-541.
12. Banerji A, Sheffer AL,. The spectrum of chronic angioedema. Allergy Asthma Proc 2009; 30: 11-16.
13. Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, et al. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema Strong correlation with the severity of disease in C1-INH concentrate naïve patients. Mol Immunol 2007; 44: 1454-1460.
14. Longhurst HJ,. Management of acute attacks of hereditary angioedema: potential role of icatibant. Vasc Health Risk Manag 2010; 6: 795-802.
15. Bowen T,. Hereditary angioedema: beyond international consensus-circa December 2010-The Canadian Society of Allergy and Clinical Immunology. Dr David McCourtie Lecture. Allergy Asthma Clin Immunol 2011; 7: 1-14.
16. Farkas H,. Pediatric hereditary angioedema due to C1-inhibitor deficiency. Allergy Asthma Clin Immunol 2010; 6: 18-27.
17. Bork K, Barnstedt SE,. Treatment of 193 Episodes of Laryngeal Edema With C1 Inhibitor Concentrate in Patients With Hereditary Angioedema. Arch Intern Med 2001; 161: 714-718.
18. Zuraw BL,. HAE Therapies: past, present, future. Allergy Asthma Clin Immunol 2010; 6: 23-30.
19. Censo Instituto Brasileiro de Geografia e Estatística. URL http://www.ibge.gov.br/home/ estatistica/populacao/censo2010/tabelas-pdf/Brasil- tab-1-11.pd (last accessed: 29 October 2011)
20. Bork K, Meng G, Staubach P, Hardt J,. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006; 119: 267-274.
21. Mallbris L, Nordenfelt P, Björkander J, Lindfors A, Werner S, Wahlgren CF,. The establishment and utility of Sweha-Reg: a Swedish population-based registry to understand hereditary angioedema. BMC Dermatol 2007; 7: 6-10.
22. Lunn ML, Santos CB, Craig TJ,. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Ann Allergy Asthma Immunol 2010; 104: 211-214.
23. Romero DS, Di Marco P, Malbrán A,. Angioedema Hereditario Historia Familiar Y Manifestaciones Clinicas em 50 Pacientes. Medicina (B Aires) 2009; 69: 601-606.
24. Craig T, Riedl M, Dykewicz MS, Gower RG, Baker J, Edelman FJ, Hurewitz D, Jacobs J, Kalfus I,. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 2009; 102: 366-372.
25. Maurer M, Magerl M,. Long-term prophylaxis of hereditary angioedema with androgen derivatives: a critical appraisal and potential alternatives. JDDG 2011; 9: 99-107.
26. Agostoni A, Cicardi M,. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992; 71: 206-15.
27. Cicardi M, Castelli R, Zingale LC, Agostoni A,. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997; 99: 194-196.
28. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B,; HAWK (Hereditary Angioedema International Working Group). Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012; 67: 147-157.